Navigation Links
Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
Date:9/10/2013

TARRYTOWN, N.Y., Sept. 10, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the appointment of Robert E. Landry as Senior Vice President, Finance.  Mr. Landry will also assume the position of Chief Financial Officer of Regeneron on October 1.  After 18 years as CFO, Murray A. Goldberg will transition to a new role as Senior Vice President, Administration in anticipation of his retirement at the end of 2014.

Mr. Landry brings over two decades of varied financial and operating experience in the global pharmaceutical industry, most recently as Senior Vice President and Treasurer of Pfizer, Inc.  He will report to Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron.  Mr. Landry will have responsibility for all financial functions, including Controller's, Treasury, Financial Planning, Tax, and Internal Audit.  In his new role, Mr. Goldberg will continue to have responsibility for Alliance Management and various administrative functions.

"Murray has been an integral member of the Regeneron senior management team for close to two decades and his contribution to our success as we grew from a development stage biotechnology company to one of the largest biotechnology companies in the world has been invaluable.  We are extremely fortunate that Murray will stay at Regeneron through 2014 to help us with the transition to a new CFO," said Dr. Schleifer.  "Bob Landry brings with him a breadth of domestic and international financial expertise at Pfizer and Wyeth.  We look forward to the valuable perspective he will bring, as we continue to expand our operations in the U.S. and globally."

"I am pleased to be able to join
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regenerons Eylea Now Captures One-Quarter Of Wet AMD Patient Share, Surpassing Share Of Roche/Genentechs Lucentis
2. Quarterly Financial Results and Development Program Updates - Research Report on Regeneron, DaVita, Celldex, Isis, and VIVUS
3. Regeneron Reports Second Quarter 2013 Financial and Operating Results
4. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
5. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
6. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
7. Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs
8. Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
9. Regeneron Pharmaceuticals Announces Expansion in New Yorks Hudson Valley
10. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
11. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
(Date:7/1/2015)... , July 1, 2015  Celsion Corporation (NASDAQ: ... announced that Michael H. Tardugno , Chairman, President ... Fitzgerald,s Inaugural Healthcare Conference on Wednesday, July 8, 2015, ... at Le Parker Meridien Hotel located at 119 W. ... 10019. A copy of the presentation will ...
(Date:7/1/2015)... Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... and chief executive officer, is scheduled to present ... an update on Egalet,s marketed product SPRIX ... product OXAYDO ™ (oxycodone HCI, USP) tablets ...
Breaking Medicine Technology:The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... June 1, 2011 Reportlinker.com ... research report is available in ... Interventional Neurology - Global ... Market Forecasts to 2017 ...
... 2011 Repro-Med Systems, Inc., (REPR.PK) announced today that ... Administration (FDA) to begin U.S. marketing of its new ... the HIgh Flo™ RMS Subcutaneous Needle Sets.  The needle ... subcutaneous tissue.  The needle sets have previously been approved ...
Cached Medicine Technology:Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12FDA Approves Marketing of RMS Subcutaneous Needle Sets 2FDA Approves Marketing of RMS Subcutaneous Needle Sets 3
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® will team ... America (HCA), as it further expands its Strategic Alliance Partnership Program for raising ... new partnership, OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted ... 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event ... petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... author Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... 17 years who participated in the National Survey on Drug Use and Health, ...
(Date:7/1/2015)... ... 2015 , ... Element Blue ™, a leading IT ... has received trademark protection for its SensorInsight® computer software platform. SensorInsight® is used ... sources providing an environment where users can view and compare real-time and historic ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest and ... two or more Bunion Booties directly from their website, http://www.BunionBootie.com can ... misaligned toes and its ultra thin properties allow for protection against rubbing footwear ...
Breaking Medicine News(10 mins):Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... Researchers from MetroHealth Medical Center and Case Western Reserve ... who have had previous spontaneous preterm births with 17 ... another preterm birth would consequently reduce both short-term and ... year. The results of their study are reported in ...
... medication labels in languages other than English, few New ... limited-English patients face serious risk of medication error, according ... Medicine presented today at the annual meeting of the ... ,"Imagine, as an English speaker, picking up ...
... out of three sexually active older adults infected with HIV ... researchers//. A survey of 260 HIV-positive older adults found that ... were in a relationship. ,AIDs cases among the ... for Disease Control and Prevention, they will account for half ...
... the potential for medication errors, says a new study by ... May issue of the journal Medical Care. ,The ... College of Pharmacy professor Daniel C. Malone, Ph.D., who is ... Research on Therapeutics at the Critical Path Institute. ...
... for their antiretroviral medications experienced interruptions in drug ... logistical disruptions. These treatment interruptions led to the ... ,These findings by a team led ... Makerere University, Kampala, and UCSF are reported in ...
... of global warming keeps coming up from across the world. ... seawaters are killing marine life in their thousands. ... ago it was reported that a Norwegian glacier had shrunk ... a usually frozen fjord (a long narrow arm of ...
Cached Medicine News:Health News:Drug Therapy can Reduce Preterm Births and Decrease Lifetime Medical Costs 2Health News:Many NYC Pharmacies Fail to Translate Prescription Labels for Patients Who Don't Understand English 2Health News:Many NYC Pharmacies Fail to Translate Prescription Labels for Patients Who Don't Understand English 3Health News:One-Third of Sexually Active Older Adults With HIV/AIDs Has Unprotected Sex 2Health News:Pharmacists' Workload Contributes To Errors 2Health News:Resistance to Anti-HIV Drugs in Uganda Developed Due to Drug Supply Problems 2Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 2Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 3
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... offers easy operation, maintenance, and training. Whether you ... to the powerful VITROS 5,1 FS, the VITROS ... right the first time. Its that simple. , ... and easy-to-use. The VITROS 350 comes complete with ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
Medicine Products: